Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01278927 · ClinicalTrials.gov registry record · NA
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 711
- Enrollment target
NCT01278927: Completed NA study, sponsored by Medical College of Wisconsin.
NCT01278927 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 711 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01278927, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 711 participants
- Enrollment target
Study Summary
This is a Phase III, randomized, unblinded, multicenter, prospective comparative study. The purpose of this study is to test whether exercise or stress management training delivered to autologous and allogeneic hematopoietic cell transplantation (HCT) patients prior to transplantation can improve functional status and the transplant experience.
Primary Outcome
To determine whether exercise or stress management improves self-reported physical and mental functioning compared to standard care at 100 days post hematopoietic cell transplantation (HCT) using evaluated patients. The Physical Component Score (PCS) and Mental Component Score (MCS) of the SF-36 will be the primary endpoint measures of functional status. Raw scores are converted to a standard metric (0-100), with higher scores being indicative of a better health state.
Interventions
- BEHAVIORAL Exercise
- OTHER Standard Care
- BEHAVIORAL Stress Management
- BEHAVIORAL Exercise and Stress Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 711 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-11 |
| Phase | NA |
What the finished NCT01278927 record still lists
NCT01278927 is an interventional study that assigns participants to a tested intervention. The registered 711 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (49% lower).
The record links to 0 conditions, and to 4 interventions - of which Exercise is the first listed.
NCT01278927 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01278927 about?
NCT01278927 is a clinical study titled "Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)". This is a Phase III, randomized, unblinded, multicenter, prospective comparative study. The purpose of this study is to test whether exercise or stress management training delivered to autologous and allogeneic hematopoietic cell transplantation (HCT) patients prior to transplantation can improve fu...
What is the current status of trial NCT01278927?
This trial is currently completed. It is a NA study. The enrollment target is 711 participants. The study started on 2011-01. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01278927?
The interventions under investigation include: Exercise (BEHAVIORAL), Standard Care (OTHER), Stress Management (BEHAVIORAL), Exercise and Stress Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT01278927?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01278927's enrollment target sits among peer trials
711 147th of 2000 higher than 1,854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06179160 · 710 participants · Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- NCT06235697 · 710 participants · Phase 3
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- NCT06470867 · 710 participants · NA
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
- NCT07022483 · 710 participants · Phase 3
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia